IGF1R and glioma: Direct links between activated IGF-1R signaling and the acquisition of stem cell- and EMT-associated properties were recently reported in the CICs of several tumors, including lung adenocarcinoma [39–40], hepatocellular carcinoma [41], colon carcinoma [42], glioma [24–25] and breast cancer [43].